[EN] LACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND CONDITIONS<br/>[FR] COMPOSÉS DE LACTAME EN TANT QU'ANTAGONISTES SÉLECTIFS DU RÉCEPTEUR EP4 POUR UNE UTILISATION DANS LE TRAITEMENT DE MALADIES ET D'ÉTATS MÉDIÉS PAR L'EP4
申请人:CAYMAN CHEMICAL CO INC
公开号:WO2014144584A2
公开(公告)日:2014-09-18
Disclosed herein are compounds of formula (I) wherein L1, L2, L3, L4, R1, R4, R5, R6, and s are as defined in the specification. Compounds of formula (I) are EP4 agonists useful in the treatment of glaucoma, osteoporosis, bone fracture, periodontal bone loss, orthopedic implant, alopecia, neuropathic pain, and related disorders. Pharmaceutical compositions and methods of treating conditions or disorders are also described.